In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain
Jorge Sepulcre(Harvard University), Keith A. Johnson(Brigham and Women's Hospital), Mert R. Sabuncu(Cornell University), Reisa A. Sperling(Harvard University), Teresa Gómez‐Isla(Harvard University), Jasmeer P. Chhatwal(Harvard University), Alex Becker(Society of Nuclear Medicine and Molecular Imaging), Aaron P. Schultz(Harvard University)
Cited by 185
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k